| Screening visit | Trial entry (Day 1) | Days 8–14 | Days 15–21 | Days 22–28 | Day 29 |
---|---|---|---|---|---|---|
Participant given PIS | x | Â | Â | Â | Â | Â |
Inclusion/Exclusion reviewed | x | x | Â | Â | Â | Â |
Consent signed | Â | x | Â | Â | Â | Â |
Daytime oximetry | Â | x | Â | x | Â | x |
Overnight oximeter issued | Â | x | Â | Â | Â | Â |
Oximeter collected | Â | Â | x | Â | Â | Â |
Spirometry | Â | x | Â | x | Â | x |
Lung volume testing (adults) | Â | x | Â | x | Â | x |
Quality of life evaluation | Â | x | Â | x | Â | x |
Blood tests/urine tests | Â | x | Â | x | Â | x |
Smartphone issued | Â | x | Â | Â | Â | Â |
Daily pain diary for next week | Â | x | x | x | x | Â |
Intervention 1 commenced | Â | Â | x | Â | Â | Â |
Sleep physiologist to review participant at home to set up intervention 1, review participant and adverse events | Â | Â | x | Â | Â | Â |
Intervention 1 stopped (courier to pick up) | Â | Â | Â | x | Â | Â |
Intervention 2 commenced | Â | Â | Â | Â | x | Â |
Sleep physiologist to review participant at home to set up intervention 2, review participant and adverse events | Â | Â | Â | Â | x | Â |
Intervention 2 stopped (courier to pick up) | Â | Â | Â | Â | Â | x |
Qualitative interview with participant and parent/guardian | Â | Â | Â | x | Â | x |
Medical/nursing review of compliance and adverse event reporting | Â | Â | Â | x | Â | x |